An announcement was made today in which Harborside Inc. (CSE: HBOR), (OTCQX: HBORF) said that it had signed a strategic agreement for cannabis crop steering research with Utah State University. The cannabis crop steering research will be led by Dr. […]
Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB:TBPMF), is a leader in cannabinoid-derived drug discovery and development. The company announces that it has signed a research collaboration agreement with Targeted Pharmaceutical and the George Mason University NCBID. As previously disclosed last quarter, Tetra […]
Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB:TBPMF) is a leader in cannabinoid-derived drug discovery and development. The company announces the results of an experimental study of its ARDS-003 investigational new drug in a model of lung injury. Tetra Bio-Pharma is a biopharmaceutical […]
MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) is a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products. The company announces its wholly-owned subsidiary, MediPharm Labs Inc., has initiated a clinical trial to research and […]
Leading cannabis research and formulation development company MedPharm Research announced today that they have been notified by the Drug Enforcement Administration (DEA) that it had been selected to move forward as one of the first applicants to be granted a […]
The Dank Investor is an industry leading cannabis financial services company providing breaking market news, analysis and leading insights about cannabis stocks for investors to grow their portfolios and minimize risk. Markets include NASDAQ, NYSE, OTC and other markets. Additionally, the company provides business services to companies in the cannabis sector through comprehensive corporate communication and marketing solutions.
The Dank Investment Community encompasses an engaged social media audience of over 50,000 who leverage our content to stay informed as investors.
We seek Safe Harbor.
